Roswell Park Cancer Institute Joins ORIEN Personalized Medicine Consortium

Drs. Carl Morrison and Candace Johnson in the Roswell Park Center for Personalized Medicine

ORIEN is a network of centers committed to supporting and relying on one another, recognizing that collaboration is the key to driving our science forward and making a difference for patients.

An unprecedented network of centers collaborating to share information and translate these pooled resources into personalized treatments for cancer patients has expanded to 16 institutions with the addition of Roswell Park Cancer Institute as a member. The National Cancer Institute-designated comprehensive cancer center has joined the Oncology Research Information Exchange Network® (ORIEN), a unique research partnership among North America’s top cancer centers.

Formed in 2014, ORIEN is an alliance of cancer centers that have committed to contribute to a shared databank and to collaborate on clinical research in order to speed new therapies to patients. Its goals are to give oncologists ready access to a searchable and ever-growing repository of medical evidence to enhance treatment decision-making and, at the same time, make any new clinical insights or precision treatment approaches informed by this data available to as many eligible patients as possible.

“Precision medicine is driving the future of cancer research and care. The ability to study specific genetic markers and mutations, and match patients to clinical trials based on that information, is crucial. Bringing more partners into ORIEN allows us to increase our patient database and, in turn, accelerate our ability to conduct such research and clinical trials,” says William S. Dalton, PhD, MD, ORIEN co-founder and founder & Executive Chair of M2Gen.

“In order to bring…

Read more from the source…

Back to Top